Oxygenators Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Oxygenators Market is Segmented by Product Type (Bubble Oxygenator and Membrane Oxygenator), Application (Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the market size and forecasts in value (USD million) for the above segments.

Market Snapshot

Oxygenators Market Overview
Study Period: 2018-2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.42 %
Oxygenators Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The oxygenators market was valued at USD 207 million in 2020, and it is poised to grow at a CAGR of 5.4% during the forecast period, 2021-2026, to reach USD 297 million by 2026.

To cope up with the current COVID-19 situation, companies are increasing the production of oxygenators globally to support the adoption of ECMO procedures for the treatment of COVID-19 patients. There has been a huge increase in demand for oxygenators in ICU units. In addition, these devices have the most significant aspects of critical care in surgical procedures and the management of COVID-19 patients; therefore, market players are launching products associated with an oxygenator. COVID-19 also impacted the production of oxygenator products in 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected medical devices such as oxygenators, especially in the first half of 2020.

The major factors driving the growth of the market are the global prevalence of various coronary heart diseases and strokes due to changing lifestyles, leading to a rise in surgical interventions, favorable reimbursement initiatives, and rapid growth of the geriatric population. For instance, according to the Global Health and Wellness Report published in 2018, nearly 40% of the adult population in the United States were diagnosed with a cardiovascular condition, which directly resulted in higher demand for coronary artery bypass procedures, leading to a rising focus on oxygenators for efficient treatments, fueling the growth of the market throughout the forecast period.

Moreover, there is a rising burden of cardiovascular diseases across the world, and they are the leading causes of death. As per the 2020 statistics provided by the World Health Organization (WHO), ischemic heart disease is responsible for 16% of the world’s total deaths. As per the same source, an estimate of 8.9 million deaths were reported for ischemic heart disease in 2019. The rising prevalence of cardiovascular diseases is driving cardiopulmonary surgeries and coronary artery bypass grafting (CABG), which may increase the demand for oxygenators.

However, the adoption of minimally invasive procedures, like percutaneous coronary interventions, risks associated with oxygenation systems, and stringent United States FDA regulations for Class II category devices, which should comply with the performance standards, are acting as barriers for the overall market growth.

Scope of the Report

An oxygenator is an essential medical device routinely used along with a heart-lung machine to facilitate the exchange of gases as a substitute for lungs during surgical procedures that may necessitate the interruption or cessation of blood flow in the body, heart, lungs, or blood vessels, like aorta, pulmonary artery, or vena cava. These devices are majorly used in cardiopulmonary surgeries and coronary artery bypass grafting (CABG) procedures. The increased adoption of oxygenators due to the availability of products specific to infants and adults may contribute to the growth of the market during the forecast period. The oxygenators market is segmented by product type (bubble oxygenator and membrane oxygenator), application (respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR)), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the market size and forecasts in value (USD million) for the above segments.

By Product Type
Bubble Oxygenator
Membrane Oxygenator
By Application
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Membrane Oxygenators Segment is Expected to Hold the Largest Market Share

The membrane oxygenators segment is expected to witness the largest market share during the forecast period due to their rising adoption in CABG procedures and extracorporeal circulation for cardiopulmonary support in various surgical procedures along with heart-lung machines due to advantages such as reduction of the damage of tissues and thrombosis compared to bubble oxygenators. Also, their rapid deployability, effective gas exchange in a relatively small membrane surface area, enhanced blood flows, less hemolysis, and less post-operative bleeding further boost the growth of the segment.

Based on application, the respiratory segment is expected to hold a major market share during the forecast period. This can be attributed to the rise in the prevalence of chronic obstructive pulmonary disease (COPD) and cardiopulmonary diseases.

Moreover, in April 2020, an Indian firm, Genrich Membranes, which the being funded by the Department of Science and Technology (DST), India, developed membrane oxygenator equipment for the treatment of COVID-19 patients. Hence, companies are working on manufacturing oxygenators as the surgeries that were put on hold during the initial days are now resuming, and thus, the demand for these devices is rising.

Oxygenators Market Key Trends

North America is Expected to Dominate the Market Over the Forecast Period

The United States has been the most affected country across the world, as the non-emergent surgical procedures were put on hold, due to which the demand for these devices will decrease. However, the surgical procedures are resuming now with proper regulating guidelines, which will further increase the demand for these oxygenators, and the market growth will gradually rise.

North America is expected to dominate the overall oxygenators market throughout the forecast period. The major factors attributing to the growth are rise in the global prevalence of multiple cardiovascular indications like CAD, ischemic strokes, and atrial fibrillation, along with acute respiratory disorders such as acute respiratory distress syndrome (ARDS), due to a rise in chronic diseases, such as diabetes and obesity, necessitating the cardiopulmonary bypass procedures and thus, rise in demand for oxygenators. For instance, according to the American Heart Association Research Report 2018, heart disease accounts for one in seven deaths in the United States. Coronary heart disease is the leading cause (43.8%) of deaths attributable to cardiovascular disease in the United States, followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), diseases of the arteries (3.1%), and other cardiovascular diseases (17.9%). This scenario is leading to a higher demand for better treatment with efficient medication, which is driving the market in the United States.

Furthermore, favorable reimbursement policies, approvals by the Food and Drug Administration (FDA), and availability of healthcare infrastructure in the region are expected to fuel the market during the forecast period.

Oxygenators Market Growth Rate

Competitive Landscape

The oxygenators market is moderately competitive and consists of several major players. Few of the key players are launching new products with advanced technologies to compete with the existing products, while others are acquiring and partnering with other companies trending in the market. For instance, in January 2019, Terumo launched its smallest, lowest prime volume, adult oxygenator, the Capiox NX19 Oxygenator. The new oxygenator uses innovative UltraPrime technology that improves patient care during cardiopulmonary bypass procedures, which contributed to the company’s growth in the cardiovascular surgery technologies market. Such product launches are expected to impel the oxygenator market’s growth throughout the forecast period. Some of the companies currently dominating the market are Medtronic PLC, Terumo Medical Corporation, Getinge AB, EUROSETS SRL, and Livanova PLC.

Recent Developments

In January 2021, Eurosets launched its new product, the ECMOlifesystem for Extra Corporeal Life Support (ECLS).

In February 2020, Chalice Medical Ltd filed a premarket notification with the United States FDA for Paragon Adult Maxi Pmp Oxygenator.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Global Prevalence of Cardiopulmonary Disorders

      2. 4.2.2 Increasing Geriatric Population, Rise in Global Healthcare Expenditure, and Growth in Disposable Income

      3. 4.2.3 Availability of Technologically Advanced Products and Reimbursement Policies

    3. 4.3 Market Restraints

      1. 4.3.1 Adoption of Minimally Invasive Procedures and Risks Associated with Oxygenation Systems

      2. 4.3.2 Stringent FDA Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size in Value)

    1. 5.1 By Product Type

      1. 5.1.1 Bubble Oxygenator

      2. 5.1.2 Membrane Oxygenator

    2. 5.2 By Application

      1. 5.2.1 Respiratory

      2. 5.2.2 Cardiac

      3. 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Chalice Medical Ltd

      2. 6.1.2 EUROSETS SRL

      3. 6.1.3 Getinge AB

      4. 6.1.4 Livanova PLC

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Microport Scientific Corporation

      7. 6.1.7 Nipro Medical Corporation

      8. 6.1.8 Terumo Medical Corporation

      9. 6.1.9 Braile Biomedica

      10. 6.1.10 Xenios AG

      11. 6.1.11 MC3 Cardiopulmonary

      12. 6.1.12 Gen World Medical Devices

      13. 6.1.13 Senko Medical Instrument Mfg Co. Ltd (MERA)

      14. 6.1.14 Owgels Group

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Oxygenators Market market is studied from 2018 - 2026.

The Global Oxygenators Market is growing at a CAGR of 5.42% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic plc, EUROSETS, Getinge AB, Livanova Plc, Terumo Medical Corporation are the major companies operating in Global Oxygenators Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!